Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 1998 September;40(3) > Panminerva Medica 1998 September;40(3):196-8

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

ORIGINAL ARTICLES   

Panminerva Medica 1998 September;40(3):196-8

Copyright © 2000 EDIZIONI MINERVA MEDICA

lingua: Inglese

Does endothelin-1 play a role in the renal function of cirrhotic patients?

Bruno C. M., D’Amico R., Ierna D., Neri S.

From the Institute of Internal and Emergency Medicine University of Catania, Catania, Italy


PDF


Meth­ods. We inves­ti­gat­ed plas­ma and uri­nary endo­the­lin-1 lev­els in ­eleven cir­rhot­ic ­patients and ten ­healthy con­trol sub­jects, to eval­u­ate wheth­er endo­the­lin is ­involved in ­renal func­tion­al alter­a­tions of liv­er cir­rho­sis.
­Results. No sig­nif­i­cant dif­fer­ence in plas­ma ET-1 lev­els was ­observed ­between the two ­groups (p>0.05) but uri­nary ET-1 excre­tion was sig­nif­i­cant­ly high­er in cir­rhot­ics ­than in con­trols (p<0.001). Crea­ti­nine clear­ance (­mean 56±7.6 ml/min) ­showed an ­inverse cor­re­la­tion ­with plas­ma ET-1 lev­els (p<0.05) in cir­rhot­ics.
Con­clu­sions. We ­believe ­this may be ­caused by ­enhanced ­local ET-1 activ­ity ­linked to an up-reg­u­la­tion of its spe­cif­ic recep­tors and/or ­increased ­renal syn­the­sis, result­ing in aug­ment­ed uri­nary excre­tion.

inizio pagina